1
|
Zhang S, Li J, Wang J, Chen X, Shu G, Feng D, Zheng X. Ferroptosis Exists in Ischemia Reperfusion Injury after Cardiac Surgery with Cardiopulmonary Bypass. Cell Biochem Biophys 2024:10.1007/s12013-024-01228-6. [PMID: 38363517 DOI: 10.1007/s12013-024-01228-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/04/2024] [Accepted: 02/02/2024] [Indexed: 02/17/2024]
Abstract
Ischemia-reperfusion (IR) injury commonly arises during cardiac surgery involving Cardiopulmonary Bypass (CPB), and it has relationship with ferroptosis in mice. However, the exact role of ferroptosis in the human cardiac damage caused by cardiac surgery remains unclear. Basic patient data and perioperative period information were collected, and clinic indicators related to cardiac function were detected to assess the extent of cardiac injury. Cardiac tissue samples were collected to determine histopathological changes, ultrastructure of mitochondrial and hallmarks of ferroptosis. 25 patients were involved in this study. In the present study, we observed a significant increase in the clinical indicator hs-cTnT, with levels rising more than 1393 ± 242 folds (P < 0.0001) following the cardiac surgery. Masson staining revealed a notable increase in fibrosis levels by 2.282 ± 0.259% (P = 0.0009). Furthermore, there was a significant elevation in lipid peroxidation, as evidenced by a 61.42 ± 17.33% increase in MDA (P = 0.0006). Additionally, we observed notable swelling, decreased mitochondrial crista, and even fragmented mitochondria. Notably, changes in the marker gene of ferroptosis were observed, with PTGS2 showing a 6.437 ± 0.81 folds increase (P < 0.0001). Furthermore, key regulators such as SLC7A11 and GPX4 proteins exhibited a reduction of 97.33 ± 25.78% (P = 0.0068) and 60.59 ± 14.93% (P = 0.0071), respectively, indicating the occurrence of ferroptosis following the surgery. Ferroptosis exists in myocardial IR injury caused by cardiac surgery with CPB, indicating that targeting ferroptosis could serve as a potential strategy for myocardial protection against CPB-induced IR injury. The trial has been registered in Chinese Clinical Trial Registry (ChiCTR, No. ChiCTR2200061995) on July 16th, 2022.
Collapse
Affiliation(s)
- Shenshen Zhang
- College of Public Health, Zhengzhou University, Department of Anaesthesia,The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
- Food Laboratory of Zhongyuan, Luohe, China
| | - Junyan Li
- College of Public Health, Zhengzhou University, Department of Anaesthesia,The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
- Food Laboratory of Zhongyuan, Luohe, China
| | - Jian Wang
- College of Public Health, Zhengzhou University, Department of Anaesthesia,The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
- Food Laboratory of Zhongyuan, Luohe, China
| | - Xi Chen
- College of Public Health, Zhengzhou University, Department of Anaesthesia,The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
- Food Laboratory of Zhongyuan, Luohe, China
| | - Guangjie Shu
- College of Public Health, Zhengzhou University, Department of Anaesthesia,The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
- Food Laboratory of Zhongyuan, Luohe, China
| | - Deguang Feng
- College of Public Health, Zhengzhou University, Department of Anaesthesia,The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - Xiangming Zheng
- College of Public Health, Zhengzhou University, Department of Anaesthesia,The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
| |
Collapse
|
2
|
George MJ, Jasmin NH, Cummings VT, Richard-Loendt A, Launchbury F, Woollard K, Turner-Stokes T, Garcia Diaz AI, Lythgoe M, Stuckey DJ, Hingorani AD, Gilroy DW. Selective Interleukin-6 Trans-Signaling Blockade Is More Effective Than Panantagonism in Reperfused Myocardial Infarction. JACC Basic Transl Sci 2021; 6:431-443. [PMID: 34095633 PMCID: PMC8165121 DOI: 10.1016/j.jacbts.2021.01.013] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/14/2020] [Revised: 01/25/2021] [Accepted: 01/25/2021] [Indexed: 12/18/2022]
Abstract
Interleukin (IL)-6 is an emerging therapeutic target in myocardial infarction (MI). IL-6 has 2 distinct signaling pathways: trans-signaling, which mediates inflammation, and classic signaling, which also has anti-inflammatory effects. The novel recombinant fusion protein sgp130Fc achieves exclusive trans-signaling blockade, whereas anti-IL-6 antibodies (Abs) result in panantagonism. In a rat model of reperfused MI, sgp130Fc, but not anti-IL-6-Ab, attenuated neutrophil and macrophage infiltration into the myocardium, reduced infarct size, and preserved cardiac function 28 days after MI. These data demonstrate the efficacy of exclusive IL-6 trans-signaling blockade and support further investigation of sgp130Fc as a potential novel therapy in MI.
Collapse
Key Words
- AAR, area at risk
- Ab, antibody
- CCL, C-C motif chemokine ligand
- CMR, cardiac magnetic resonance
- CXCL, C-X-C motif ligand
- ICAM-1, intercellular adhesion molecule 1
- IL, interleukin
- IS, infarct size
- LGE, late-gadolinium enhancement
- LVEF, left ventricular ejection fraction
- MHC, major histocompatibility complex
- MI, myocardial infarction
- NSTEMI, non–ST-segment-elevation MI
- RCAEC, rat coronary artery endothelial cell
- STEMI, ST-segment-elevation MI
- TCZ, tocilizumab
- Trop-T, troponin T
- c-caspase-3, cleaved caspase-3
- inflammation
- interleukin-6
- myocardial infarction
- reperfusion
- sIL-6R, soluble IL-6 receptor
Collapse
Affiliation(s)
- Marc Jonathan George
- Department of Clinical Pharmacology, Division of Medicine, University College London, London, United Kingdom
- Department of Clinical Pharmacology, University College London Hospitals NHS Foundation Trust, London, United Kingdom
| | - Nur Hayati Jasmin
- Centre for Advanced Biomedical Imaging (CABI), Division of Medicine, University College London, London, United Kingdom
| | - Valerie Taylor Cummings
- Centre for Advanced Biomedical Imaging (CABI), Division of Medicine, University College London, London, United Kingdom
| | - Angela Richard-Loendt
- Department of Neuropathology, University College London Hospitals NHS Foundation Trust, London, United Kingdom
- UCL IQPath, Institute of Neurology, University College London, London, United Kingdom
| | - Francesca Launchbury
- UCL IQPath, Institute of Neurology, University College London, London, United Kingdom
| | - Kevin Woollard
- Immunology and Inflammation, Faculty of Medicine, Imperial College London, London, United Kingdom
| | - Tabitha Turner-Stokes
- Immunology and Inflammation, Faculty of Medicine, Imperial College London, London, United Kingdom
| | - Ana Isabel Garcia Diaz
- Immunology and Inflammation, Faculty of Medicine, Imperial College London, London, United Kingdom
| | - Mark Lythgoe
- Centre for Advanced Biomedical Imaging (CABI), Division of Medicine, University College London, London, United Kingdom
| | - Daniel James Stuckey
- Centre for Advanced Biomedical Imaging (CABI), Division of Medicine, University College London, London, United Kingdom
| | - Aroon Dinesh Hingorani
- Department of Clinical Pharmacology, University College London Hospitals NHS Foundation Trust, London, United Kingdom
- Centre for Translational Genomics, Institute of Cardiovascular Science, University College London, London, United Kingdom
| | - Derek William Gilroy
- Department of Clinical Pharmacology, Division of Medicine, University College London, London, United Kingdom
| |
Collapse
|
3
|
Ho DR, Chang PJ, Lin WY, Huang YC, Lin JH, Huang KT, Chan WN, Chen CS. Beneficial Effects of Inflammatory Cytokine-Targeting Aptamers in an Animal Model of Chronic Prostatitis. Int J Mol Sci 2020; 21:ijms21113953. [PMID: 32486412 PMCID: PMC7312664 DOI: 10.3390/ijms21113953] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/04/2020] [Revised: 05/26/2020] [Accepted: 05/28/2020] [Indexed: 01/10/2023] Open
Abstract
Non-bacterial prostatitis is an inflammatory disease that is difficult to treat. Oligonucleotide aptamers are well known for their stability and flexibility in conjugating various inflammatory molecules. In this study, we investigated the effects of inflammatory cytokine-targeting aptamers (ICTA), putative neutralizers of TNF-alpha and IL-1 beta activation, on local carrageenan-induced prostate inflammation, allodynia, and hyperalgesia in rats. In vitro evaluation confirmed the binding capability of ICTA. Intraprostatic injection of carrageenan or control vehicle was performed in six-week-old rats, and ICTA (150 µg) or vehicle was administered in the prostate along with carrageenan injection. The von Frey filament test was performed to determine mechanical allodynia, and prostate inflammation was examined seven days after drug administration. Local carrageenan administration resulted in a reduction of the tactile threshold. The levels of mononuclear cell infiltration, pro-inflammatory cytokine interleukin-1 beta (b), caspase-1 (casp-1), and Nucleotide-binding oligomerization domain, Leucine rich Repeat and Pyrin domain containing proteins 1 and 3 (NALP1 and NALP3) in the prostate of rats were increased seven days after carrageenan injection. Treatment with ICTA significantly attenuated the carrageenan-induced hyperalgesia and reduced the elevated levels of proteins including TNF-a and IL-1b in the rats. Apoptosis markers, B-cell lymphoma 2-associated X protein (Bax) and caspase-3, were elevated in ICTA-treated Chronic pelvic pain syndrome (CPPS) rats. These results suggest that ICTA provides protection against local carrageenan-induced enhanced pain sensitivity, and that the neutralization of proinflammatory cytokines may result in inflammatory cell apoptosis.
Collapse
Affiliation(s)
- Dong-Ru Ho
- Division of Urology, Department of Surgery, Chang Gung Memorial Hospital, Chiayi 613016, Taiwan; (D.-R.H.); (W.-Y.L.); (Y.-C.H.); (J.-H.L.); (K.-T.H.); (W.-N.C.)
- Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Taoyuan City 333323, Taiwan;
- Department of Nursing, Chang Gung University of Science and Technology, Chiayi 613016, Taiwan
- Department of Medicine, College of Medicine, Chang Gung University, Taoyuan City 333323, Taiwan
| | - Pey-Jium Chang
- Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Taoyuan City 333323, Taiwan;
| | - Wei-Yu Lin
- Division of Urology, Department of Surgery, Chang Gung Memorial Hospital, Chiayi 613016, Taiwan; (D.-R.H.); (W.-Y.L.); (Y.-C.H.); (J.-H.L.); (K.-T.H.); (W.-N.C.)
| | - Yun-Ching Huang
- Division of Urology, Department of Surgery, Chang Gung Memorial Hospital, Chiayi 613016, Taiwan; (D.-R.H.); (W.-Y.L.); (Y.-C.H.); (J.-H.L.); (K.-T.H.); (W.-N.C.)
| | - Jian-Hui Lin
- Division of Urology, Department of Surgery, Chang Gung Memorial Hospital, Chiayi 613016, Taiwan; (D.-R.H.); (W.-Y.L.); (Y.-C.H.); (J.-H.L.); (K.-T.H.); (W.-N.C.)
| | - Kuo-Tsai Huang
- Division of Urology, Department of Surgery, Chang Gung Memorial Hospital, Chiayi 613016, Taiwan; (D.-R.H.); (W.-Y.L.); (Y.-C.H.); (J.-H.L.); (K.-T.H.); (W.-N.C.)
| | - Wai-Nga Chan
- Division of Urology, Department of Surgery, Chang Gung Memorial Hospital, Chiayi 613016, Taiwan; (D.-R.H.); (W.-Y.L.); (Y.-C.H.); (J.-H.L.); (K.-T.H.); (W.-N.C.)
| | - Chih-Shou Chen
- Division of Urology, Department of Surgery, Chang Gung Memorial Hospital, Chiayi 613016, Taiwan; (D.-R.H.); (W.-Y.L.); (Y.-C.H.); (J.-H.L.); (K.-T.H.); (W.-N.C.)
- Correspondence: ; Tel.: +886-975-353211
| |
Collapse
|
4
|
Salameh A, Dhein S, Mewes M, Sigusch S, Kiefer P, Vollroth M, Seeger J, Dähnert I. Anti-oxidative or anti-inflammatory additives reduce ischemia/reperfusions injury in an animal model of cardiopulmonary bypass. Saudi J Biol Sci 2019; 27:18-29. [PMID: 31889812 PMCID: PMC6933174 DOI: 10.1016/j.sjbs.2019.04.003] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/05/2018] [Revised: 04/01/2019] [Accepted: 04/03/2019] [Indexed: 01/02/2023] Open
Abstract
Severe inborn cardiac malformations are typically corrected in cardioplegia, with a cardio-pulmonary bypass (CPB) taking over body circulation. During the operation the arrested hearts are subjected to a global ischemia/reperfusion injury. Although the applied cardioplegic solutions have a certain protective effect, application of additional substances to reduce cardiac damage are of interest. 18 domestic piglets (10–15 kg) were subjected to a 90 min CPB and a 120 min reperfusion phase without or with the application of epigallocatechin-3-gallate (10 mg/kg body weight) or minocycline (4 mg/kg body weight), with both drugs given before and after CPB. 18 additional sham-operated piglets without or with epigallocatechin-3-gallate or minocycline served as controls. In total 36 piglets were analyzed (3 CPB-groups and 3 control groups without or with epigallocatechin-3-gallate or minocycline respectively; 6 piglets per group). Hemodynamic and blood parameters and ATP-measurements were assessed. Moreover, a histological evaluation of the heart muscle was performed. Results Piglets of the CPB-group needed more catecholamine support to achieve sufficient blood pressure. Ejection fraction and cardiac output were not different between the 6 groups. However, cardiac ATP-levels and blood lactate were significantly lower and creatine kinase was significantly higher in the three CPB-groups. Markers of apoptosis, hypoxia, nitrosative and oxidative stress were significantly elevated in hearts of the CPB-group. Nevertheless, addition of epigallocatechin-3-gallate or minocycline significantly reduced markers of myocardial damage. Noteworthy, EGCG was more effective in reducing markers of hypoxia, whereas minocycline more efficiently decreased inflammation. Conclusions While epigallocatechin-3-gallate or minocycline did not improve cardiac hemodynamics, markers of myocardial damage were significantly lower in the CPB-groups with epigallocatechin-3-gallate or minocycline supplementation.
Collapse
Key Words
- ACT, activated clotting time
- AEC, 3-amino-9-ethylcarbazole
- AIF, apoptosis-inducing factor
- CO, cardiac output
- CPB, cardio-pulmonary bypass
- Cardio-pulmonary bypass
- DNA, deoxyribonucleic acid
- EF, ejection fraction
- EGCG, epigallo-3-catechin-gallate
- EGCG, ischemia/reperfusion injury
- HIF1α, hypoxia-inducible factor α
- HPLC, high pressure liquid chromatography
- Heart
- MPTP, mitochondrial permeability transition pore
- Minocycline
- NT, nitrotyrosine
- PAR, poly-ADP-ribose
- PARP, poly-ADP-ribose polymerase
- ROS, reactive oxygen species
- TNFα, tumor necrosis factor α
- cC3, cleaved caspase-3
Collapse
Affiliation(s)
- Aida Salameh
- University of Leipzig, Heart Centre Clinic for Paediatric Cardiology, Germany
- Corresponding author at: University of Leipzig, Heart Centre Clinic for Paediatric Cardiology, Struempellstrasse 39, 04289 Leipzig, Germany.
| | - Stefan Dhein
- University of Leipzig, Rudolf-Boehm-Institute for Pharmacology and Toxicology, Germany
| | - Marie Mewes
- University of Leipzig, Heart Centre Clinic for Paediatric Cardiology, Germany
| | - Sophie Sigusch
- University of Leipzig, Heart Centre Clinic for Paediatric Cardiology, Germany
| | - Philipp Kiefer
- University of Leipzig, Heart Center, Department of Cardiac Surgery, Leipzig, Germany
| | - Marcel Vollroth
- University of Leipzig, Heart Center, Department of Cardiac Surgery, Leipzig, Germany
| | - Johannes Seeger
- University of Leipzig, Institute of Vetinary Anatomy, Histology and Embryology, Germany
| | - Ingo Dähnert
- University of Leipzig, Heart Centre Clinic for Paediatric Cardiology, Germany
| |
Collapse
|